113 related articles for article (PubMed ID: 10882020)
1. Biaryl diacid inhibitors of human s-PLA2 with anti-inflammatory activity.
Springer DM; Luh BY; Bronson JJ; McElhone KE; Mansuri MM; Gregor KR; Nettleton DO; Stanley PL; Tramposch KM
Bioorg Med Chem; 2000 May; 8(5):1087-109. PubMed ID: 10882020
[TBL] [Abstract][Full Text] [Related]
2. Suppression of inflammatory responses by surfactin, a selective inhibitor of platelet cytosolic phospholipase A2.
Kim K; Jung SY; Lee DK; Jung JK; Park JK; Kim DK; Lee CH
Biochem Pharmacol; 1998 Apr; 55(7):975-85. PubMed ID: 9605421
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet phospholipase A2 activity by catuaba extract suggests antiinflammatory properties.
Barbosa NR; Fischmann L; Talib LL; Gattaz WF
Phytother Res; 2004 Nov; 18(11):942-4. PubMed ID: 15597313
[TBL] [Abstract][Full Text] [Related]
4. Anti-phospholipase A2 and anti-inflammatory activity of Santolina chamaecyparissus.
Sala A; Recio MC; Giner RM; Máñez S; Ríos JL
Life Sci; 2000; 66(2):PL35-40. PubMed ID: 10666016
[TBL] [Abstract][Full Text] [Related]
5. Novel inhibitor of phospholipase A2 with topical anti-inflammatory activity.
Tramposch KM; Steiner SA; Stanley PL; Nettleton DO; Franson RC; Lewin AH; Carroll FI
Biochem Biophys Res Commun; 1992 Nov; 189(1):272-9. PubMed ID: 1449483
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of trimethoxyphenyl isoxazolidines as inhibitors of secretory phospholipase A2 with anti-inflammatory activity.
Sadashiva MP; Nataraju A; Mallesha H; Rajesh R; Vishwanath BS; Rangappa KS
Int J Mol Med; 2005 Nov; 16(5):895-904. PubMed ID: 16211261
[TBL] [Abstract][Full Text] [Related]
7. N-(carboxymethyl)-N-[3,5-bis(decyloxy)-phenyl]glycine (Ro 23-9358): a potent inhibitor of secretory phospholipases A2 with antiinflammatory activity.
LeMahieu RA; Carson M; Han RJ; Madison VS; Hope WC; Chen T; Morgan DW; Hendrickson HS
J Med Chem; 1993 Oct; 36(20):3029-31. PubMed ID: 8411020
[No Abstract] [Full Text] [Related]
8. Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.
Marshall LA; Winkler JD; Griswold DE; Bolognese B; Roshak A; Sung CM; Webb EF; Jacobs R
J Pharmacol Exp Ther; 1994 Feb; 268(2):709-17. PubMed ID: 8113982
[TBL] [Abstract][Full Text] [Related]
9. Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2.
Miyake A; Yamamoto H; Kubota E; Hamaguchi K; Kouda A; Honda K; Kawashima H
Br J Pharmacol; 1993 Sep; 110(1):447-53. PubMed ID: 8220906
[TBL] [Abstract][Full Text] [Related]
10. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation.
Garcia-Pastor P; Randazzo A; Gomez-Paloma L; Alcaraz MJ; Paya M
J Pharmacol Exp Ther; 1999 Apr; 289(1):166-72. PubMed ID: 10087000
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli. Cleavage of a fusion protein with cyanogen bromide.
Franken PA; Van den Berg L; Huang J; Gunyuzlu P; Lugtigheid RB; Verheij HM; De Haas GH
Eur J Biochem; 1992 Jan; 203(1-2):89-98. PubMed ID: 1730245
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and comparison of the antiinflammatory activity of manoalide and cacospongionolide B analogues.
De Rosa M; Giordano S; Scettri A; Sodano G; Soriente A; Pastor PG; Alcaraz MJ; Payá M
J Med Chem; 1998 Aug; 41(17):3232-8. PubMed ID: 9703468
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of human platelet phospholipase A2 activity by unsaturated fatty acids.
Ballou LR; Cheung WY
Proc Natl Acad Sci U S A; 1985 Jan; 82(2):371-5. PubMed ID: 3855556
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of 2-oxoamide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2.
Six DA; Barbayianni E; Loukas V; Constantinou-Kokotou V; Hadjipavlou-Litina D; Stephens D; Wong AC; Magrioti V; Moutevelis-Minakakis P; Baker SF; Dennis EA; Kokotos G
J Med Chem; 2007 Aug; 50(17):4222-35. PubMed ID: 17672443
[TBL] [Abstract][Full Text] [Related]
15. The novel natural product YM-26567-1 [(+)-trans-4-(3-dodecanoyl-2,4,6- trihydroxyphenyl)-7-hydroxy-2-(4-hydroxyphenyl)chroman]: a competitive inhibitor of group II phospholipase A2.
Miyake A; Yamamoto H; Takebayashi Y; Imai H; Honda K
J Pharmacol Exp Ther; 1992 Dec; 263(3):1302-7. PubMed ID: 1469636
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2).
Glaser KB; Carlson RP; Sung A; Bauer J; Lock YW; Holloway D; Sturm R; Hartman D; Walter T; Woeppel S
Agents Actions; 1993; 39 Spec No():C30-2. PubMed ID: 8273577
[TBL] [Abstract][Full Text] [Related]
17. An update on inhibitors of human 14 kDa Type II s-PLA2 in development.
Springer DM
Curr Pharm Des; 2001 Feb; 7(3):181-98. PubMed ID: 11311112
[TBL] [Abstract][Full Text] [Related]
18. Effects of marine 2-polyprenyl-1,4-hydroquinones on phospholipase A2 activity and some inflammatory responses.
Gil B; Sanz MJ; Terencio MC; De Giulio A; De Rosa S; Alcaraz MJ; Payá M
Eur J Pharmacol; 1995 Oct; 285(3):281-8. PubMed ID: 8575515
[TBL] [Abstract][Full Text] [Related]
19. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
[TBL] [Abstract][Full Text] [Related]
20. Manoalide.
Soriente A; De Rosa MM; Scettri A; Sodano G; Terencio MC; Payá M; Alcaraz MJ
Curr Med Chem; 1999 May; 6(5):415-31. PubMed ID: 10101221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
